Αρχειοθήκη ιστολογίου

Δευτέρα 5 Μαρτίου 2018

A new delivery system to resolve dosimetric issues in intravascular brachytherapy

S15384721.gif

Publication date: Available online 5 March 2018
Source:Brachytherapy
Author(s): Joseph M. DeCunha, Shirin A. Enger
PurposeRenewed interest is being expressed in intravascular brachytherapy (IVBT). A number of unresolved issues exist in the discipline. Providing a homogeneous and adequate dose to the target remains difficult in IVBT. The guidewire that delivers the device to the target, arterial plaques, and stent struts are all known to reduce the dose delivered to target. The viability and efficacy of a proposed IVBT delivery system designed to resolve the issue of guidewire attenuation is evaluated and compared to that of a popular and commercially available IVBT device.Methods and MaterialsMonte Carlo simulations are conducted to determine distributions of absorbed dose around an existing and proposed IVBT delivery system.ResultsFor the Novoste Beta-Cath 3.5F (TeamBest®), dose in water varies by 10% as a function of angle in the plane perpendicular to the delivery catheter due to off-centering of seeds in the catheter. Dose is reduced by 52% behind a stainless steel guidewire and 64% behind a guidewire, arterial plaque, and stent strut for the Novoste Beta-Cath 3.5F. Dose is not perturbed by the presence of a guidewire for the proposed device and is reduced by 46% by an arterial plaque and stent strut.ConclusionsDose attenuation by guidewire is likely the single greatest source of dose attenuation in IVBT in terms of absolute dose reduction and is greater than previously reported for the Novoste Beta-Cath 3.5F. The Novoste Beta-Cath 3.5F delivers an inhomogeneous dose to target. A delivery system is proposed, which resolves the issue of guidewire attenuation in IVBT and should reduce treatment times.



from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2FpfRVx

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου